Baycrest

Rotman Research Institute Annual Report 2016

Baycrest Health Sciences & Baycrest Foundation Publications

Issue link: http://baycrest.uberflip.com/i/740910

Contents of this Issue

Navigation

Page 10 of 27

11 Rotman Research Institute Annual Report 2015-2016 Dr. Jean Chen Scientist, RRI Assistant Professor Department of Medical Biophysics University of Toronto Research Focus: Neuroimaging & Aging Diagnosing dementia using fMRI Dr. Randy McIntosh Director, RRI Professor Department of Psychology University of Toronto Research Focus: Computational Neuroscience Dr. Stephen Strother Senior Scientist, RRI Professor Department of Medical Biophysics University of Toronto Research Focus: Neuroinformatics & Neuroimaging IMAGING & INFORMATICS Researchers have focused efforts towards stopping the spread of toxic amyloid plaques in the brain, a hallmark of Alzheimer's disease, but Dr. Jean Chen is forging a new path to stop the illness. Scientists have shown that blood flow to our brain declines with age and that vascular disease is present in 90% of patients with dementia on autopsy. In older adults, vascular dysfunction is a strong risk factor for dementia and greater insight into vascular health could provide an earlier diagnosis. Using Functional Magnetic Resonance Imaging (fMRI), scientists can measure the brain's functionality through its use of blood and oxygen which allows them to assess vascular elasticity, a measurement linked to vascular health. To do so, participants are typically exposed to a stimulus, such as a special gas mixture, to trigger temporary brain changes. However, this technique can be uncomfortable and intolerable for older adults. Dr. Chen leveraged her engineering background to pioneer a new fMRI technique that remedies these issues. Her non-invasive, resting-state cerebrovascular-elasticity mapping technique brings research one step closer to using fMRI as a diagnostic tool to detect signs of neurodegenerative diseases earlier and start interventions sooner. Her work could also lead to measuring the impact of treatments and interventions on the brain. She was the first scientist to use MRI to investigate the link between the decline of blood flow and brain shrinkage during aging and her technique has captured the attention of the scientific community. In 2016, Dr. Chen was recognized as a health leader by the Canadian Institutes of Health Research with a Foundation Grant for new investigators. In 2015, her method was published in a prominent, peer-reviewed journal, NeuroImage, and she has since filed a patent application. Meanwhile, her technique has been adopted by top researchers in various healthcare institutions to study dementia, stroke, and late-life depression. As a next step, Dr. Chen will incorporate electroencephalography (EEG) - which captures the brain's electrical activity - into her technique to clarify the source of the fMRI signal. This will improve fMRI's diagnostic ability as a tool to help differentiate between different neurodegenerative diseases.

Articles in this issue

Links on this page

view archives of Baycrest - Rotman Research Institute Annual Report 2016